ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
663
|
242K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
Danielguda1
|
99 |
33K |
3 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
99
|
33K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
2 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
663
|
242K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
663
|
242K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
663
|
242K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
663
|
242K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
663
|
242K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
0 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
663
|
242K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
1 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
663
|
242K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
1 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
663
|
242K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
2 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
663
|
242K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
2 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
663
|
242K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
663
|
242K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
3 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
663
|
242K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
663
|
242K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
2 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
663
|
242K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
6 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
663
|
242K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
9 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
663
|
242K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
3 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
663
|
242K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
7 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
663
|
242K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Theranostic prostate cancer trial advances to cohort 3
|
|
Danielguda1
|
65 |
16K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
65
|
16K
|
2
|
|
ASX - By Stock
|
CU6 |
Research/Valuation
|
|
Danielguda1
|
663 |
242K |
22 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
663
|
242K
|
22
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Theranostic prostate cancer trial advances to cohort 3
|
|
Danielguda1
|
65 |
16K |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
65
|
16K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Theranostic prostate cancer trial advances to cohort 3
|
|
Danielguda1
|
65 |
16K |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
65
|
16K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Theranostic prostate cancer trial advances to cohort 3
|
|
Danielguda1
|
65 |
16K |
8 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
65
|
16K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Theranostic prostate cancer trial advances to cohort 3
|
|
Danielguda1
|
65 |
16K |
9 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
65
|
16K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Theranostic prostate cancer trial advances to cohort 3
|
|
Danielguda1
|
65 |
16K |
7 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
65
|
16K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
The FDA is a corrupt organization.
|
|
Danielguda1
|
155 |
58K |
1 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
155
|
58K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
The FDA is a corrupt organization.
|
|
Danielguda1
|
155 |
58K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
155
|
58K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
Danielguda1
|
138 |
46K |
3 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
138
|
46K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
Danielguda1
|
138 |
46K |
8 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
138
|
46K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1B brain cancer clinical trial approved for initiation
|
|
Danielguda1
|
13 |
4.1K |
0 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
13
|
4.1K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1B brain cancer clinical trial approved for initiation
|
|
Danielguda1
|
13 |
4.1K |
2 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
13
|
4.1K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Change of Registry Address
|
|
Danielguda1
|
2 |
941 |
4 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
2
|
941
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
3 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
452
|
163K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
452
|
163K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
1 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
452
|
163K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
3 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
452
|
163K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
5 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
452
|
163K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
2 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
452
|
163K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
0 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
452
|
163K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
6 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
452
|
163K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
0 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
452
|
163K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
0 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
452
|
163K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
4 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
452
|
163K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
0 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
452
|
163K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
3 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
452
|
163K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
2 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
452
|
163K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
0 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
452
|
163K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Danielguda1
|
452 |
163K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
452
|
163K
|
1
|
|